Evidence map›Paper›PMID 39180048›Full record

ArticleJournal of biomedical science2024

Machine learning enabled classification of lung cancer cell lines co-cultured with fibroblasts with lightweight convolutional neural network for initial diagnosis.

Adam Germain, Alex Sabol, Anjani Chavali, Giles Fitzwilliams, Alexa Cooper, Sandra Khuon, Bailey Green, Calvin Kong, John Minna, Young-Tae Kim

Abstract read
In one paragraph

Article in Journal of biomedical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adam GermainDepartment of Bioengineering, University of Texas at Arlington, 500 UTA Blvd ERB244, Arlington, TX, 76010, USA.
Alex SabolDepartment of Computer Science, University of Texas at Arlington, Arlington, TX, USA.
Anjani ChavaliDepartment of Bioengineering, University of Texas at Arlington, 500 UTA Blvd ERB244, Arlington, TX, 76010, USA.
Giles FitzwilliamsDepartment of Bioengineering, University of Texas at Arlington, 500 UTA Blvd ERB244, Arlington, TX, 76010, USA.
Alexa CooperDepartment of Biology, University of Texas at Arlington, Arlington, TX, USA.
Sandra KhuonDepartment of Nursing, University of Texas at Arlington, Arlington, TX, USA.
Bailey GreenDepartment of Bioengineering, University of Texas at Arlington, 500 UTA Blvd ERB244, Arlington, TX, 76010, USA.
Calvin KongDepartment of Bioengineering, University of Texas at Arlington, 500 UTA Blvd ERB244, Arlington, TX, 76010, USA.
John MinnaHamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Young-Tae KimDepartment of Bioengineering, University of Texas at Arlington, 500 UTA Blvd ERB244, Arlington, TX, 76010, USA. ykim@uta.edu.ORCID http://orcid.org/0000-0002-5725-3709

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
Lung Cancer SPORE P50-CA070907NCI NIH HHS P50 CA070907
6 · The paper itself

Abstract

backgroundIdentification of lung cancer subtypes is critical for successful treatment in patients, especially those in advanced stages. Many advanced and personal treatments require knowledge of specific mutations, as well as up- and down-regulations of genes, for effective targeting of the cancer cells. While many studies focus on individual cell structures and delve deeper into gene sequencing, the present study proposes a machine learning method for lung cancer classification based on low-magnification cancer outgrowth patterns in a 2D co-culture environment.

methodsUsing a magnetic well plate holder, circular pattern lung cancer cell clusters were generated among fibroblasts, and daily images were captured to monitor cancer outgrowth over a 9-day period. These outgrowth images were then augmented and used to train a convolutional neural network (CNN) model based on the lightweight TinyVGG architecture. The model was trained with pairs of classes representing three subtypes of NSCLC: A549 (adenocarcinoma), H520 (squamous cell carcinoma), and H460 (large cell carcinoma). The objective was to assess whether this lightweight machine learning model could accurately classify the three lung cancer cell lines at different stages of cancer outgrowth. Additionally, cancer outgrowth images of two patient-derived lung cancer cells, one with the KRAS oncogene and the other with the EGFR oncogene, were captured and classified using the CNN model. This demonstration aimed to investigate the translational potential of machine learning-enabled lung cancer classification.

resultsThe lightweight CNN model achieved over 93% classification accuracy at 1 day of outgrowth among A549, H460, and H520, and reached 100% classification accuracy at 7 days of outgrowth. Additionally, the model achieved 100% classification accuracy at 4 days for patient-derived lung cancer cells. Although these cells are classified as Adenocarcinoma, their outgrowth patterns vary depending on their oncogene expressions (KRAS or EGFR).

conclusionsThese results demonstrate that the lightweight CNN architecture, operating locally on a laptop without network or cloud connectivity, can effectively create a machine learning-enabled model capable of accurately classifying lung cancer cell subtypes, including those derived from patients, based upon their outgrowth patterns in the presence of surrounding fibroblasts. This advancement underscores the potential of machine learning to enhance early lung cancer subtyping, offering promising avenues for improving treatment outcomes in advanced stage-patients.

Indexed as

Coculture TechniquesFibroblastsLung NeoplasmsMachine LearningNeural Networks, ComputerCarcinoma, Non-Small-Cell LungCell Line, TumorHumansClassificationCo-cultureLung cancerMachine learningOn-device diagnosis

Identifiers

PMID39180048
PMCPMC11344461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.